Presently, definitive diagnosis of AD is established upon post-mortem brain tissue examination confirming the presence of aggregated amyloid-β (Aβ) peptides into Aβ plaques and hyperphosphorylated tau protein into neurofibrillary tangles (NFTs) [9, 11]. Here, MAPT is linked to Alzheimer disease.